NCT01492166已完成不适用
A Multi-center, Prospective, Non-interventional Evaluation of Efficacy, Safety and Convenience of Mixtard® 30 NovoLet® as Monotherapy, or in Combination With Oral Hypoglycaemic Agent ( OHA ), in Treatment of Subjects With Type 2 Diabetes in Routine Clinical Practice
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 1,935
- 试验地点
- 1
- 主要终点
- Change in fasting blood glucose (FBG)
研究概览
简要总结
This study is conducted in Asia. The aim of this study is to assess the efficacy, safety and convenience of the use of Mixtard® 30 NovoLet® used alone or combined with oral hypoglycaemic agent (OHA) in the management of type 2 diabetes mellitus in an out-patient setting.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Type 2 diabetes
- •Not adequately controlled on their current therapy
排除标准
- 未提供
研究组 & 干预措施
Novolet®
干预措施: biphasic human insulin 30 (Drug)
结局指标
主要结局
Change in fasting blood glucose (FBG)
Change in 2-hour post prandial blood glucose
Change in HbA1c (glycosylated haemoglobin)
Change in prandial glucose increment (PGI)
次要结局
- Frequency of minor and major hypoglycaemia
- Occurrence of Adverse Drug Reactions (ADR)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Observational Study to Evaluate Safety, Efficacy and Convenience of Using NovoMix® 30 FlexPen® in Type 2 DiabetesDelivery SystemsDiabetesDiabetes Mellitus, Type 2NCT00715663Novo Nordisk A/S1,584
已完成
不适用
An Observational Study Evaluating Efficacy, Safety and Convenience of NovoNorm® in Treatment of Type 2 Diabetes in Routine Clinical PracticeDiabetesDiabetes Mellitus, Type 2NCT01498900Novo Nordisk A/S30,554
撤回
不适用
Safety and Efficacy Study of NovoRapid™ in Patients With Coexisting Diabetes and Kidney DiseaseDiabetesChronic Kidney DiseaseDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1NCT00849316Novo Nordisk A/S
已完成
不适用
A Study to Evaluate Safety and Effectiveness in Patients of All Age Groups Excluding Less Than 12 Months Old Infants With Diabetes Mellitus in Routine Clinical Practice in KoreaDiabetesNCT02779413Novo Nordisk A/S3,303
已完成
不适用
An Observational Study to Assess Safety and Effectiveness of Intravenous NovoRapid® in Hospitalised SubjectsDiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2NCT00700648Novo Nordisk A/S3,024